Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) ROCE % : 0.00% (As of Nov. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Cannabis Bioscience International Holdings's annualized ROCE % for the quarter that ended in Nov. 2023 was 0.00%.

Cannabis Bioscience International Holdings ROCE % Historical Data

The historical data trend for Cannabis Bioscience International Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings ROCE % Chart

Cannabis Bioscience International Holdings Annual Data

Trend

Dec06

Dec07

May09

May10

May11

ROCE %

100.17

-33.39

24.72

Cannabis Bioscience International Holdings Semi-Annual Data
	Dec06	Jun07	Dec07	Jun08	May09	Nov09	May10	Nov10	May11	Nov11	Nov22	Nov23
ROCE %	Get a 7-Day Free Trial							34.99	13.99	21.70	-1.03	-

Cannabis Bioscience International Holdings ROCE % Calculation

Cannabis Bioscience International Holdings's annualized ROCE % for the fiscal year that ended in May. 2011 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: May. 2011 )		(A: May. 2010 )		(A: May. 2011 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: May. 2011 )		(A: May. 2010 )		(A: May. 2011 )
	=	14.571	/	( ( (71.714 - 19.399)	+	(93.043 - 27.459) )	/ 2 )
	=	14.571	/	( (52.315	+	65.584)	/ 2 )
	=	14.571	/	58.9495
	=	24.72 %

Cannabis Bioscience International Holdings's ROCE % of for the quarter that ended in Nov. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Nov. 2023 )		(Q: Nov. 2022 )		(Q: Nov. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Nov. 2023 )		(Q: Nov. 2022 )		(Q: Nov. 2023 )
	=	-0.536	/	( ( (0 - 0)	+	(0.102 - 0.66) )	/ 1 )
	=	-0.536	/	( ( 0	+	-0.558 )	/ 1 )
	=	-0.536	/	-0.558
	=	0 %

(1) Note: The EBIT data used here is two times the semi-annual (Nov. 2023) EBIT data.

Cannabis Bioscience International Holdings (OTCPK:CBIH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Cannabis Bioscience International Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6201 Bonhomme Road, Suite 466S, Houston, TX, USA, 77036

Website

https://www.cbih.net

Cannabis Bioscience International Holdings Inc is engaged in providing educational systems relating to cannabis and services in therapeutic areas. of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, video courses, seminars, royalties, and merchandise sales. The company generates the majority of its revenue from clinical trials.